Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists

Molecular Pharmacology

Volumn 62, Issue 3, 2002, Pages 705-713

  Andersson, David A ^a   Adner, Mikael ^b   Högestätt, Edward D ^a   Zygmunt, Peter M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; ARACHIDONOYL 5 METHOXYTRYPTAMINE; CANNABINOID RECEPTOR; CAPSAICIN; CAPSAZEPINE; CARBACHOL; DEXANABINOL; ENALAPRILAT; HISTAMINE; INDOMETACIN; N(G) NITROARGININE; NOLPITANTIUM; OLVANIL; PROSTAGLANDIN SYNTHASE; RESINIFERATOXIN; RIMONABANT; SAREDUTANT; THIORPHAN; TIMOLOL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; BRONCHUS; COMPARATIVE STUDY; COMPUTER MODEL; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG COMPETITION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; GUINEA PIG; HYDROLYSIS; LUNG PARENCHYMA; MALE; MESENTERIC ARTERY; MUSCLE CONTRACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSORY NERVE; TISSUE DISTRIBUTION; VASOCONSTRICTION;

ANIMALS; ARACHIDONIC ACIDS; BRONCHI; BRONCHIAL ARTERIES; CALCIUM CHANNEL BLOCKERS; CAPSAICIN; COMPUTER SIMULATION; GUINEA PIGS; LUNG; MALE; MESENTERIC ARTERIES; POLYUNSATURATED ALKAMIDES; RECEPTORS, DRUG;

EID: 0036765293     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.3.705     Document Type: Article

References (53)

1. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, and Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science (Wash DC) 277:1094-1097.
2. Black JW and Lett P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141-162.
3. Braud S, Bon C, Touqui L, and Mounier C (2000) Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. FEBS Lett 471:12-16.
4. Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, and Piomelli D (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature (Lond) 408:96-101.
5. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond) 389:816-824.
6. Craib SJ, Ellington HC, Pertwee RG, and Ross RA (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br J Pharmacol 134:30-37.
7. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, and Di Marzo V (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483:52-56.
8. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, and Di Marzo V (2001a) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856-12863.
9. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, and Di Marzo V (2001b) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77:1660-1663.
10. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
11. Di Marzo V, De Petrocellis L, Sepe N, and Buono A (1996) Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J 316:977-984.
12. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, and Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (Lond) 372:686-691.
13. Ellis JL and Undem BJ (1994) Inhibition by capsazepine of resiniferatoxin- and capsaicin-induced contractions of guinea pig trachea. J Pharmacol Exp Ther 268:85-89.
14. Franco-Cereceda A (1991) Rosiniferatoxin-, capsaicin- and CGRP-evoked porcine coronary vasodilatation is independent of EDRF mechanisms but antagonized by CGRP(8-37). Acta Physiol Scand 143:331-337.
15. Fujimori A, Saito A, Kimura S, and Goto K (1990) Release of calcitonin gene-related peptide (CGRP) from capsaicin-sensitive vasodilator nerves in the rat mesenteric artery. Neurosci Lett 112:173-178.
16. Girard V, Feletou M, Advenier C, and Canet E (1997) Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea. Br J Pharmacol 122:841-848.
17. Grainger J and Boachie-Ansah G (2001) Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134:1003-1012.
18. Högestätt ED, Andersson KE, and Edvinsson L (1983) Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49-61.
19. Holzer P (1991) Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol Rev 43:143-201.
20. Holzer P (1992) Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121:49-146.
21. Hughes SR, Buckley TL, and Brain SD (1992) Olvanil: more potent than capsaicin at stimulating the efferent function of sensory nerves. Eur J Pharmacol 219:481-484.
22. Jansen I, Alafaci C, Uddman R, and Edvinsson L (1990) Evidence that calcitonin gene-related peptide contributes to the capsaicin-induced relaxation of guinea pig cerebral arteries. Regul Pept 31:167-178.
23. Jordt SE and Julius D (2002) Molecular Basis for species-specific sensitivity to "hot" chili peppers. Cell 108:421-430.
24. Julius D and Basbaum AI (2001) Molecular mechanisms of nociception. Nature (Lond) 413:203-210.
25. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, and Oh U (1999) Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19:529-538.
26. Lundberg JM (1995) Tachykinins, sensory nerves and asthma-an overview. Can J Physiol Pharmacol 73:908-914.
27. Lundberg JM (1996) Pharmacology of contransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48:113-178.
28. Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, and Finazzi-Agro A (2000) Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J Biol Chem 275:13484-13492
29. Macarrone M, van der Stelt M, Rossi A, Veldink GA, Vliegenthart JF, and Agro AF (1998) Anandamide hydrolysis by human cells in culture and brain. J Biol Chem 273:32332-32339.
30. Maggi CA (1991) The pharmacology of the efferent function of sensory nerves. J Auton Pharmacol 11:173-208.
31. Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, and Di Marzo V (1999) Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem Biophys Res Commun 262:275-284.
32. Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA, Caterina MJ, Clapham DE, Harteneck C, Heller S, Julius D, et al. (2002) A unified nomenclature for the superfamily of TRP cation channels. Mol Cell 9:229-231.
33. Olah Z, Karai L, and Iadarola MJ (2001) Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 276:31163-31170.
34. Pratt PF, Hillard CJ, Edgemond WS, and Campbell WB (1998) N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 274:H375-H381.
35. Premkumar LS and Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature (Lond) 408:985-990.
36. Ralevic V, Kendall DA, Jerman JC, Middlemiss DN, and Smart D (2001) Cannabinoid activation of recombinant and andogenous vanilloid receptors. Eur J Pharmacol 424:211-219.
37. Richardson JD, Aanonsen L, and Hargreavas KM (1998a) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345:145-153.
38. Richardson JD, Kilo S, and Hargreaves KM (1999b) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75:111-119.
39. Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, and Pertwee RG (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br J Pharmacol 132:631-640.
40. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, and David JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
41. Stengel PW, Rippy MK, Cockerham SL, Devane WA, and Silbaugh SA (1998) Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. Eur J Pharmacol 355:57-66.
42. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
43. Szallasi A, Blumberg PM, Annicelli LL, Krause JE, and Cortright DN (1999) The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 56:581-587.
44. 3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat. J Pharmacol Exp Ther 267:728-733.
45. Szolcsanyi J and Jancso-Gabor A (1975) Sensory effects of capsaicin congeners. I. Relationship between chemical structure and pain-producing potency of pungent agents. Arzneimittelforschung 25:1877-1881.
46. Tucker RC, Kagaya M, Page CP, and Spina D (2001) The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br J Pharmacol 132:1127-1135.
47. Urban L, Campbell EA, Panesar M, Patel S, Chaudhry N, Kane S, Buchheit K, Sandells B, and James IF (2000) In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue. Pain 89:65-74.
48. Vellani V, Mapplebeck S, Moriondo A, Davis JB, and McNaughton PA (2001) Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol (Lond) 534:813-825.
49. Wardle KA, Ranson J, and Sanger CJ (1997) Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord Br J Pharmacol 121:1012-1016.
50. White CB, Roberts AM, and Joshua IG (1993) Arteriolar dilation mediated by capsaicin and calcitonin gene-related peptide in rats. Am J Physiol 265:H1411-H1415.
51. Wrigglesworth R, Walpole CS, Bevan S, Campbell EA, Dray A, Hughes GA, James I, Masdin KJ, and Winter J (1996) Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics. J Med Chem 39:4942-4951.
52. Zygmunt PM, Chuang H, Movahed P, Julius D, and Hogestatt ED (2000) The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 396:39-42.
53. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, and Högestätt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-457.